Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07487584Not Yet Recruiting

Study of Genetics in Childhood Obesity

Role: collaborator

NCT07350395Recruiting

Exploring and Measuring the Impact of Steroids in Children and Young People

Role: collaborator

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT04196192Completed

Febrile Infants - Diagnostic Assessment and Outcome

Role: collaborator

NCT04382508Unknown

Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.

Role: collaborator

NCT01815632Phase 2Unknown

Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)

Role: collaborator

NCT02205931Phase 4Unknown

Ketogenic Diet in Infants With Epilepsy (KIWE)

Role: collaborator

All 7 trials loaded